News

Novo Holdings’ $16.5 billion Catalent buy leads 2024’s M&A deals so far

2024-06-28

In the first five months of 2024, there was a surge in high-value deals, though none have yet matched the scale of Pfizer’s $43 billion acquisition of Seagen, which closed in December 2023. With Novo Holdings’ $16.5 billion purchase of Catalent leading the pack, 2024 reflects a mixed but strong trend toward sizable M&A activity. The Novo deal helps it address surging demand for its GLP-1 receptor agonist products, including Ozempic and Wegovy, according to data from the market-intelligence firm

MORE DETAILS

GeoVax Advances COVID-19 Vaccine with Up to $45M from BARDA

2024-06-27

Agency plans $343M award for CRO to carry out 10,000-patient Phase IIb trial comparing company’s dual-antigen GEO-CM04S1 to an approved jab. GeoVax Labs is launching a 10,000-participant Phase IIb trial comparing the efficacy, safety, and immunogenicity of the company’s next-generation, dual-antigen COVID-19 vaccine GEO-CM04S1 to one of the current FDA-approved COVID vaccines—a study being funded by the Biomedical Advanced Research and Development Authority (BARDA). [GeoVax Labs]

MORE DETAILS

6 signs AI momentum in drug discovery is building

2024-06-25

MORE DETAILS

The 100 best-funded biotech companies from 2015 to present

2024-06-01

In early 2022, secretive Altos Labs emerged with a sizable $3 billion launch to pursue anti-aging “cellular rejuvenation” amid rumors of Jeff Bezos’ backing. The company is the best-funded biotech in recent memory.

MORE DETAILS

Top pharma companies ranked by 2023 R&D spend

2024-06-01

Which major pharmaceutical company leads the way in research and development? Data reveals that the top R&D spender in 2023 was Merck & Co., by a wide margin. While Pfizer had almost as much revenue as Merck ($60.1 billion vs. $58.5 billion), its R&D ratio was on the lower end at 18.29%, or $10.7 billion.

MORE DETAILS

Biopharma clusters in flux: Who’s hiring, firing and building in biopharma in the first half of 2024

2024-05-16

The biopharma’s layoff woes continue to make headlines, but the news is not all negative. To get a clearer picture, we gathered data on layoffs, new plant plant...

MORE DETAILS

Top 25 Biotech Companies of 2024

2024-05-16

Combined market cap falls 2% year over year, with 16 of the largest public companies losing value and just 5 outperforming the S&P 500

MORE DETAILS

Could Single Technologies’ 3D Sequencing Deliver the $10 Genome?

2024-05-16

The cube-style sequencing solution, which could increase the number of DNA sequences read in parallel, has caught the eye of Illumina veteran Bob Kain, and might naturally unify sequencing with spatial biology

MORE DETAILS

共 69 条

About us: Our products include chemicals and biologicals for scientific research in biology (cell biology, molecular biology and protein biology research), vaccine generation and production, biomedical diagnosis. and veterinary hygiene. Our company alos provides high quality products, optimal advanced technology solutions to help customers accelerate the progress of transitioning their research products to manufacturing or serving the medical care.
We distribute reagents, consumables and laboratory equipment for molecular biology, biotechnology, biochemistry, molecular diagnostics, quality control, tissue culture, forensic as well as genomics, proteomics and in vitro fertilization centers. We represent companies of recognized trajectory and, together with them, we are committed to the development and productive efficiency in science.

View More

Contact Us: 6TH FLOOR,TOWER 1, NO.8 CHANGXIANG ROAD,SHANGHAI, PR.CHINA; [email protected]; Phone:+86-021-31430785 Mob: +86-15901864269 Whatsapp:+86 15901864269

Newsletter: Lorem ipsum dolor si consectetur adipisicing elit, sed eiusmotempor incididunt ut labore et

Follow Us